BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lymphoma AND EZH2, ENX-1, 2146, ENSG00000106462, Q15910, MGC9169 AND Diagnosis
30 results:

  • 1.
    Choi YJ; Min YK; Lee ST; Choi JR; Shin S
    Ann Lab Med; 2024 Jul; 44(4):335-342. PubMed ID: 38145892
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Performance of the cobas ezh2 mutation test on clinical samples from non-Hodgkin lymphoma patients.
    Shyu JY; Schlag PA; Karwowska SM; Manohar CF; Truong HM; Longshore JW; Zhang G
    PLoS One; 2023; 18(12):e0292251. PubMed ID: 38096164
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Clinicopathologic Features of Therapy-Related Myeloid Neoplasms in Patients with Myeloma in the Era of Novel Therapies.
    Jelloul FZ; Quesada AE; Yang RK; Li S; Wang W; Xu J; Tang G; Yin CC; Fang H; El Hussein S; Khoury J; Bassett RL; Garcia-Manero G; Manasanch EE; Orlowski RZ; Qazilbash MH; Patel KP; Medeiros LJ; Lin P
    Mod Pathol; 2023 Jun; 36(6):100166. PubMed ID: 36990279
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Combined Reverse-Transcriptase Multiplex Ligation-Dependent Probe Amplification and Next-Generation Sequencing Analyses to Assign Unclassified BCL2
    Sesboue C; Galtier J; Jeanneau M; Chauvel A; Laharanne E; Amintas S; Merlio JP; Bouabdallah K; Gros FX; de Leval L; Gros A; Parrens M
    Mod Pathol; 2023 Feb; 36(2):100043. PubMed ID: 36853790
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Prevalence of IRF4 rearrangement in large B-cell lymphomas of the Waldeyer's ring in adults.
    Streich S; Frauenfeld L; Otto F; Mankel B; Bonzheim I; Fend F; Quintanilla-Martinez L
    Virchows Arch; 2023 Mar; 482(3):551-560. PubMed ID: 36810796
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Single-cell profiling reveals a memory B cell-like subtype of follicular lymphoma with increased transformation risk.
    Wang X; Nissen M; Gracias D; Kusakabe M; Simkin G; Jiang A; Duns G; Sarkozy C; Hilton L; Chavez EA; Segat GC; Wong R; Kim J; Aoki T; Islam R; May C; Hung S; Tyshchenko K; Brinkman RR; Hirst M; Karsan A; Freeman C; Sehn LH; Morin RD; Roth AJ; Savage KJ; Craig JW; Shah SP; Steidl C; Scott DW; Weng AP
    Nat Commun; 2022 Nov; 13(1):6772. PubMed ID: 36351924
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. The characteristics of cerebrospinal fluid anaplastic large cells in a patient with primary leptomeningeal anaplastic large cell lymphoma.
    Ruan H; Wang Z; Chen K; Tang X; Ding T; Zhang C; Guan M
    Clin Chim Acta; 2022 Dec; 537():46-50. PubMed ID: 36243040
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. ezh2 mutations at diagnosis in follicular lymphoma: a promising biomarker to guide frontline treatment.
    Martínez-Laperche C; Sanz-Villanueva L; Díaz Crespo FJ; Muñiz P; Martín Rojas R; Carbonell D; Chicano M; Suárez-González J; Menárguez J; Kwon M; Diez Martín JL; Buño I; Bastos Oreiro M
    BMC Cancer; 2022 Sep; 22(1):982. PubMed ID: 36104682
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. H3K27m3 overexpression as a new, BCL2 independent diagnostic tool in follicular and cutaneous follicle center lymphomas.
    Brune MM; Vela V; Bratic Hench I; Dertinger S; Borgmann V; Dirnhofer S; Tzankov A
    Virchows Arch; 2022 Sep; 481(3):489-497. PubMed ID: 35661922
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Oncogenetic landscape of T-cell lymphoblastic lymphomas compared to T-cell acute lymphoblastic leukemia.
    Bontoux C; Simonin M; Garnier N; Lhermitte L; Touzart A; Andrieu G; Bruneau J; Lengliné E; Plesa A; Boissel N; Baruchel A; Bertrand Y; Molina TJ; Macintyre E; Asnafi V
    Mod Pathol; 2022 Sep; 35(9):1227-1235. PubMed ID: 35562412
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Follicular lymphoma: a Focus on Current and Emerging Therapies.
    Cahill KE; Smith SM
    Oncology (Williston Park); 2022 Feb; 36(2):97-106. PubMed ID: 35180337
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Decreased expression of T-cell-associated immune markers predicts poor prognosis in patients with follicular lymphoma.
    Rai S; Inoue H; Sakai K; Hanamoto H; Matsuda M; Maeda Y; Haeno T; Watatani Y; Kumode T; Serizawa K; Taniguchi Y; Hirase C; Espinoza JL; Morita Y; Tanaka H; Ashida T; Tatsumi Y; Nishio K; Matsumura I
    Cancer Sci; 2022 Feb; 113(2):660-673. PubMed ID: 34837284
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Epigenetics of Indolent lymphoma and How It Drives Novel Therapeutic Approaches-Focus on ezh2-Targeted Drugs.
    Longley J; Johnson PWM
    Curr Oncol Rep; 2021 May; 23(7):76. PubMed ID: 33937922
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Genomic landscape of cutaneous follicular lymphomas reveals 2 subgroups with clinically predictive molecular features.
    Zhou XA; Yang J; Ringbloom KG; Martinez-Escala ME; Stevenson KE; Wenzel AT; Fantini D; Martin HK; Moy AP; Morgan EA; Harkins S; Paxton CN; Hong B; Andersen EF; Guitart J; Weinstock DM; Cerroni L; Choi J; Louissaint A
    Blood Adv; 2021 Feb; 5(3):649-661. PubMed ID: 33560380
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. The hematopoietic stem cell marker VNN2 is associated with chemoresistance in pediatric B-cell precursor ALL.
    Bornhauser B; Cario G; Rinaldi A; Risch T; Rodriguez Martinez V; Schütte M; Warnatz HJ; Scheidegger N; Mirkowska P; Temperli M; Möller C; Schumich A; Dworzak M; Attarbaschi A; Brüggemann M; Ritgen M; Mejstrikova E; Hofmann A; Buldini B; Scarparo P; Basso G; Maglia O; Gaipa G; Skoblyn TL; Te Kronnie G; Vendramini E; Panzer-Grümayer R; Barz MJ; Marovca B; Hauri-Hohl M; Niggli F; Eckert C; Schrappe M; Stanulla M; Zimmermann M; Wollscheid B; Yaspo ML; Bourquin JP
    Blood Adv; 2020 Sep; 4(17):4052-4064. PubMed ID: 32853382
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Potential of Circulating Tumor DNA for the Management of Patients With lymphoma.
    Huet S; Salles G
    JCO Oncol Pract; 2020 Sep; 16(9):561-568. PubMed ID: 32421389
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. ezh2 Downregulation Augments the Effect of Irradiation in Reducing Pancreatic Cancer Cell Proliferation
    Agrawal R; Chen M; Bukhari Z; Ogunwobi OO; Haseeb MA; Martello LA
    Ann Clin Lab Sci; 2020 Jan; 50(1):45-56. PubMed ID: 32161011
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Utility of Combined ezh2, p-ERK1/2, p-STAT, and MYC Expression in the Differential diagnosis of ezh2-positive Hodgkin lymphomas and Related Large B-Cell lymphomas.
    Tian X; Xu J; Dorfman DM
    Am J Surg Pathol; 2019 Jan; 43(1):102-109. PubMed ID: 30371509
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Acute Lymphoblastic Leukemia with Hypereosinophilia in a Child: Case Report and Literature Review.
    Ferruzzi V; Santi E; Gurdo G; Arcioni F; Caniglia M; Esposito S
    Int J Environ Res Public Health; 2018 Jun; 15(6):. PubMed ID: 29867057
    [No Abstract]    [Full Text] [Related]  

  • 20. Concomitant 1p36 deletion and TNFRSF14 mutations in primary cutaneous follicle center lymphoma frequently expressing high levels of ezh2 protein.
    Gángó A; Bátai B; Varga M; Kapczár D; Papp G; Marschalkó M; Kuroli E; Schneider T; Csomor J; Matolcsy A; Bödör C; Szepesi Á
    Virchows Arch; 2018 Oct; 473(4):453-462. PubMed ID: 29858685
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.